Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1060M-50Tests

AF647 Anti-Human CD47 Antibody[CC2C6D4]

AF647 Anti-Human CD47 Antibody[CC2C6D4]

Regular price $180.00 USD
Regular price Sale price $180.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the AF647 Anti-Human CD47 Antibody[CC2C6D4], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of experts, exhibits exceptional specificity and affinity towards the CD47 protein, a key regulator of immune responses in humans.

The AF647 Anti-Human CD47 Antibody[CC2C6D4] boasts an advanced AF647 fluorochrome conjugation, enabling precise and reliable detection of CD47 expression in various biological samples. Its superior performance is attributed to the utilization of the CC2C6D4 clone, which has been rigorously validated for its exceptional binding characteristics and minimal cross-reactivity.

This antibody's unparalleled efficacy is further enhanced by its compatibility with a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for comprehensive analysis of CD47 expression patterns in diverse experimental settings, facilitating groundbreaking discoveries in the realms of cancer research, immunotherapy, and autoimmune diseases.

Moreover, the AF647 Anti-Human CD47 Antibody[CC2C6D4] exhibits exceptional stability and reproducibility, ensuring consistent and reliable results across multiple experiments. Its formulation has been optimized to minimize non-specific binding, thereby reducing background noise and enhancing signal-to-noise ratios.

In summary, the AF647 Anti-Human CD47 Antibody[CC2C6D4] represents a state-of-the-art solution for researchers and clinicians alike, seeking to unravel the intricate mechanisms underlying immune regulation. With its unrivaled specificity, compatibility, and reliability, this antibody is poised to revolutionize the field of immunology and drive advancements in therapeutic interventions.
View full details